LOTTE BIOLOGICS is pleased to announce that James Park will assume the role of Chief Executive Officer, effective December 11, 2024.

Mr. Park brings with him an impressive track record in operational excellence, strategic leadership, and corporate growth. With his extensive experience, he is well-positioned to guide LOTTE BIOLOGICS toward becoming a key player in the global Contract Development and Manufacturing Organization (CDMO) market. His leadership will also play a pivotal role in strengthening the collaboration between our teams in Korea and the United States.

To celebrate his appointment and mark the beginning of this exciting new chapter, an inauguration ceremony was held at the Songdo Bio Campus site on December 13. This significant event underscores LOTTE BIOLOGICS’ commitment to innovation and growth under Mr. Park’s leadership.

Under his guidance, LOTTE BIOLOGICS aims to achieve transformative milestones, accelerate global expansion, and foster a united, innovative culture across the organization.